WS 5570 non-inferior to paroxetine in moderate-to-severe depression

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1475, 2005-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-term escitalopram beats paroxetine for severe depression

Inpharma, Vol. 1, Iss. 1543, 2006-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Emerging drugs for moderate-to-severe psoriasis

By Magliocco Melissa A

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 1, 2005-02 ,pp. : 35-52

Informa Healthcare

Access to resources Recommend Favorite

SSRIs in conjunction with cognitive behavioural therapy (CBT), compared with an SSRI alone, do not improve outcomes for children and adolescents with moderate-to-severe depression

Inpharma, Vol. 1, Iss. 1593, 2007-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Ustekinumab useful for moderate-to-severe plaque psoriasis

Inpharma, Vol. 1, Iss. 1624, 2008-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Pharmacological treatment in moderate-to-severe Alzheimer's disease

By Hsiung Ging-Yuek Robin Feldman Howard H

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 15, 2008-10 ,pp. : 2575-2582

Informa Healthcare

Access to resources Recommend Favorite